Literature DB >> 24108656

Temporal bone squamous cell carcinoma: analyzing prognosis with univariate and multivariate models.

Elisabetta Zanoletti1, Gino Marioni, Paola Stritoni, Marco Lionello, Luciano Giacomelli, Alessandro Martini, Antonio Mazzoni.   

Abstract

OBJECTIVES/HYPOTHESIS: Temporal bone squamous cell carcinoma (SCC) is an uncommon malignancy accounting for less than 0.2% of head and neck cancers. Despite advances in its early diagnosis, skull base microsurgery, radiotherapy, and integrated treatments, prognosis in advanced SCCs remains dismal. The present study aimed to analyze the clinicopathological variables potentially influencing outcome in a series of temporal bone SCCs. STUDY
DESIGN: The prognosis of 41 patients with temporal bone SCC was assessed retrospectively using univariate and multivariate statistical approaches. PATIENTS AND METHODS: Twenty-two women and 19 men consecutively operated for primary temporal bone SCC with a curative intent at a tertiary referral center between 1980 and 2008.
RESULTS: On univariate analysis, cT stage correlated with disease-free survival in months (DFS) (P = 0.037), and pT stage correlated with recurrence rate (P = 0.038), DFS (P = 0.013), and disease-specific survival (DSS) (P = 0.025). Lymph node status (cN0 or pN0 vs. pN+) was associated with DFS (P = 0.025). SCC grading correlated significantly with recurrence rate (P = 0.005), DFS (P = 0.004), and DSS (P = 0.0036). Dura mater involvement was significantly associated with a higher recurrence rate (P = 0.001), a shorter DFS (P = 0.00001), and a lower DSS (P = 0.0001). On multivariate analysis, only dura mater involvement (P = 0.001) and N status (P = 0.012) remained independently prognostic of DFS.
CONCLUSION: Recurrences occurred despite obtaining block resections according to the tumor's clinical stage and pathologically free margins in all cases. Further analyses are mandatory to investigate hidden microscopic pathways of tumor diffusion, particularly in bone. Multi-institutional protocols are needed to facilitate comparisons between studies and enable meaningful meta-analyses.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Temporal bone carcinoma; dura mater involvement; lymph node; multivariate analysis; prognosis

Mesh:

Year:  2013        PMID: 24108656     DOI: 10.1002/lary.24400

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

1.  Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma.

Authors:  Go Omura; Mizuo Ando; Yuki Saito; Osamu Fukuoka; Ken Akashi; Masafumi Yoshida; Akinobu Kakigi; Takahiro Asakage; Tatsuya Yamasoba
Journal:  Int J Clin Oncol       Date:  2017-01-02       Impact factor: 3.402

2.  Histological characteristics of intra-temporal facial nerve paralysis in temporal bone malignancies.

Authors:  Omer J Ungar; Joseph B Nadol; William C Faquin; John P Carey; Ophir Handzel; Felipe Santos
Journal:  Laryngoscope       Date:  2019-08-01       Impact factor: 3.325

Review 3.  Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors.

Authors:  Gino Marioni; Alessandro Martini; Niccolò Favaretto; Sebastiano Franchella; Rocco Cappellesso; Filippo Marino; Stella Blandamura; Antonio Mazzoni; Elisabetta Zanoletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-30       Impact factor: 2.503

4.  Relaxin-2 expression in temporal bone carcinoma.

Authors:  Gino Marioni; Elisabetta Zanoletti; Andrea Lovato; Sebastiano Franchella; Luciano Giacomelli; Andrea Gianatti; Antonio Mazzoni; Stella Blandamura; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-12       Impact factor: 2.503

5.  Temporal bone carcinoma: Classical prognostic variables revisited and modern clinico-pathological evidence.

Authors:  Elisabetta Zanoletti; Gino Marioni; Sebastiano Franchella; Sara Munari; Roberto Pareschi; Antonio Mazzoni; Alessandro Martini
Journal:  Rep Pract Oncol Radiother       Date:  2015-09-29

6.  Surgical treatment for squamous cell carcinoma of the temporal bone: predictors of survival.

Authors:  Conrad F Smit; Niels de Boer; Birgit I Lissenberg-Witte; Paul Merkus; Erik F Hensen; C René Leemans
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-08       Impact factor: 2.124

Review 7.  Treatment Strategies for Malignancies of the External Auditory Canal.

Authors:  Shixun Zhong; Wenqi Zuo
Journal:  Curr Treat Options Oncol       Date:  2022-02-15

Review 8.  Squamous cell carcinoma of the temporal bone: A current review.

Authors:  Benjamin D Lovin; Paul W Gidley
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-11-13

9.  Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.

Authors:  Cindy H Nabuurs; Wietske Kievit; Nilou Labbé; C René Leemans; Conrad F G M Smit; Michiel W M van den Brekel; Robert J Pauw; Bernard F A M van der Laan; Jeroen C Jansen; Martin Lacko; Weibel W Braunius; Shinya Morita; Małgorzata Wierzbicka; Takuma Matoba; Nobuhiro Hanai; Robert P Takes; Henricus P M Kunst
Journal:  Head Neck       Date:  2020-08-13       Impact factor: 3.147

Review 10.  Malignant tumors of the temporal bone - our experience.

Authors:  Ana Pereira da Silva; Eduardo Breda; Eurico Monteiro
Journal:  Braz J Otorhinolaryngol       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.